Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

Background In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, in...

Full description

Saved in:
Bibliographic Details
Published in:Immunity & ageing Vol. 13; no. 1; p. 21
Main Authors: Puzianowska-Kuźnicka, Monika, Owczarz, Magdalena, Wieczorowska-Tobis, Katarzyna, Nadrowski, Pawel, Chudek, Jerzy, Slusarczyk, Przemyslaw, Skalska, Anna, Jonas, Marta, Franek, Edward, Mossakowska, Malgorzata
Format: Journal Article
Language:English
Published: London BioMed Central 03.06.2016
BioMed Central Ltd
Springer Nature B.V
Subjects:
ISSN:1742-4933, 1742-4933
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. Results IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n  = 3496 individuals, p  < 0.001 and CRP: n  = 3632, p  = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n  = 1258, p  < 0.001 and CRP: n  = 1312, p  < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n  = 2238, p < 0.001 and CRP: n  = 2320, p  = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p  < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p  < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p  < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p  < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p  < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p  < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p  < 0.001). Conclusions Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1742-4933
1742-4933
DOI:10.1186/s12979-016-0076-x